Equity - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
	Mar. 01, 2022	Mar. 31, 2022	Dec. 31, 2021	Jul. 16, 2021
Stockholders Equity Details [Line Items]
Common stock, shares authorized		730,000,000	730,000,000
Common stock, par value (in Dollars per share)		$ 0.0001	$ 0.0001	$ 0.0001
Common stock, voting Rights		common stock are entitled to one vote per share
Preferred stock, shares authorized		10,000,000	10,000,000
Preferred stock, shares issued		0	0
Preferred stock, shares outstanding		0	0
Proceeds from the exercise of warrants		$ 46,485
Warrants outstanding		29,404,809
Warrants
Stockholders Equity Details [Line Items]
Call price of public warrants		$ 0.01
Minimum prior written notice period for redemption		30 days
Description of call provision		• at any time while the Public Warrants are exercisable,   • upon not less than 30 days’ prior written notice of redemption to each Public Warrant holder,   • if, and only if, there is a current registration statement in effect with respect to the issuance of the common stock underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing
Legacy Celularity
Stockholders Equity Details [Line Items]
Warrants outstanding to purchase shares of common stock	13,281,386
Number of shares issued	13,281,386
Issuance cost of equity	$ 15,985
Minimum | Legacy Celularity
Stockholders Equity Details [Line Items]
Exercise per share price (in Dollars per share)	$ 3.50
Exercise price	3.50
Minimum | Legacy Celularity | Preferred Stock
Stockholders Equity Details [Line Items]
Percentage of shares required for voting		50.00%
Maximum | Legacy Celularity
Stockholders Equity Details [Line Items]
Exercise per share price (in Dollars per share)	7.53
Exercise price	$ 7.53
Class A Common Stock
Stockholders Equity Details [Line Items]
Common stock, shares authorized		730,000,000
Common stock, par value (in Dollars per share)		$ 0.0001		$ 0.0001
Warrants outstanding		29,494,809
Class A Common Stock | Legacy Celularity
Stockholders Equity Details [Line Items]
Proceeds from the exercise of warrants	$ 46,485